Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.

Hoyo C, Grubber J, Demark-Wahnefried W, Lobaugh B, Jeffreys AS, Grambow SC, Marks JR, Keku TO, Walther PJ, Schildkraut JM.

J Natl Med Assoc. 2009 Jul;101(7):711-6.

2.

Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.

Fowke JH, Matthews CE, Yu H, Cai Q, Cohen S, Buchowski MS, Zheng W, Blot WJ.

Endocr Relat Cancer. 2010 Jan 29;17(1):51-60. doi: 10.1677/ERC-09-0023. Print 2010 Mar.

3.

Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whites.

Hoyo C, Grubber J, Demark-Wahnefried W, Marks JR, Freedland SJ, Jeffreys AS, Grambow SC, Wenham RM, Walther PJ, Schildkraut JM.

J Natl Med Assoc. 2007 Jul;99(7):718-22.

4.

IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.

Schildkraut JM, Demark-Wahnefried W, Wenham RM, Grubber J, Jeffreys AS, Grambow SC, Marks JR, Moorman PG, Hoyo C, Ali S, Walther PJ.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):403-8.

5.

Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults.

Hand BD, Kostek MC, Ferrell RE, Delmonico MJ, Douglass LW, Roth SM, Hagberg JM, Hurley BF.

J Appl Physiol (1985). 2007 Nov;103(5):1678-87. Epub 2007 Aug 30.

6.

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.

Schumacher FR, Cheng I, Freedman ML, Mucci L, Allen NE, Pollak MN, Hayes RB, Stram DO, Canzian F, Henderson BE, Hunter DJ, Virtamo J, Manjer J, Gaziano JM, Kolonel LN, Tjønneland A, Albanes D, Calle EE, Giovannucci E, Crawford ED, Haiman CA, Kraft P, Willett WC, Thun MJ, Le Marchand L, Kaaks R, Feigelson HS, Bueno-de-Mesquita HB, Palli D, Riboli E, Lund E, Amiano P, Andriole G, Dunning AM, Trichopoulos D, Stampfer MJ, Key TJ, Ma J.

Hum Mol Genet. 2010 Aug 1;19(15):3089-101. doi: 10.1093/hmg/ddq210. Epub 2010 May 19.

7.

Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.

Biong M, Gram IT, Brill I, Johansen F, Solvang HK, Alnaes GI, Fagerheim T, Bremnes Y, Chanock SJ, Burdett L, Yeager M, Ursin G, Kristensen VN.

BMC Med Genomics. 2010 Mar 19;3:9. doi: 10.1186/1755-8794-3-9.

8.

Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.

Slattery ML, Sweeney C, Wolff R, Herrick J, Baumgartner K, Giuliano A, Byers T.

Breast Cancer Res Treat. 2007 Aug;104(2):197-209. Epub 2006 Oct 19.

PMID:
17051426
9.

Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.

Costalonga EF, Antonini SR, Guerra G Jr, Coletta RR, Franca MM, Braz AF, Mendonca BB, Arnhold IJ, Jorge AA.

Pharmacogenomics J. 2012 Oct;12(5):439-45. doi: 10.1038/tpj.2011.13. Epub 2011 Apr 5.

PMID:
21468024
10.

Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.

Keku TO, Vidal A, Oliver S, Hoyo C, Hall IJ, Omofoye O, McDoom M, Worley K, Galanko J, Sandler RS, Millikan R.

Cancer Causes Control. 2012 Jul;23(7):1127-38. doi: 10.1007/s10552-012-9981-2. Epub 2012 May 8.

11.

IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men.

Yeap BB, Chubb SA, Ho KK, Setoh JW, McCaul KA, Norman PE, Jamrozik K, Flicker L.

Eur J Endocrinol. 2010 Feb;162(2):249-57. doi: 10.1530/EJE-09-0852. Epub 2009 Nov 16.

12.

Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.

Pechlivanis S, Wagner K, Chang-Claude J, Hoffmeister M, Brenner H, Försti A.

Cancer Detect Prev. 2007;31(5):408-16. Epub 2007 Nov 26.

PMID:
18031946
13.

IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.

Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM.

Hum Mol Genet. 2006 Jan 1;15(1):1-10. Epub 2005 Nov 23.

14.

Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.

Gu F, Schumacher FR, Canzian F, Allen NE, Albanes D, Berg CD, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Buring JE, Chabbert-Buffet N, Chanock SJ, Clavel-Chapelon F, Dumeaux V, Gaziano JM, Giovannucci EL, Haiman CA, Hankinson SE, Hayes RB, Henderson BE, Hunter DJ, Hoover RN, Johansson M, Key TJ, Khaw KT, Kolonel LN, Lagiou P, Lee IM, LeMarchand L, Lund E, Ma J, Onland-Moret NC, Overvad K, Rodriguez L, Sacerdote C, Sánchez MJ, Stampfer MJ, Stattin P, Stram DO, Thomas G, Thun MJ, Tjønneland A, Trichopoulos D, Tumino R, Virtamo J, Weinstein SJ, Willett WC, Yeager M, Zhang SM, Kaaks R, Riboli E, Ziegler RG, Kraft P.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2877-87. doi: 10.1158/1055-9965.EPI-10-0507. Epub 2010 Sep 1.

15.

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, Berg CD, Buring J, Calle EE, Chanock S, Clavel-Chapelon F, Cox DG, Dorronsoro M, Dossus L, Haiman CA, Hankinson SE, Henderson BE, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Kraft P, Linseisen J, Lund E, Manjer J, McCarty C, Peeters PH, Pike MC, Pollak M, Riboli E, Stram DO, Tjonneland A, Travis RC, Trichopoulos D, Tumino R, Yeager M, Ziegler RG, Feigelson HS; Breast and Prostate Cancer Cohort Consortium.

PLoS One. 2008 Jul 2;3(7):e2578. doi: 10.1371/journal.pone.0002578.

16.

Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.

Cheng I, DeLellis Henderson K, Haiman CA, Kolonel LN, Henderson BE, Freedman ML, Le Marchand L.

J Clin Endocrinol Metab. 2007 Sep;92(9):3660-6. Epub 2007 Jun 12.

PMID:
17566087
17.

Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.

Terry KL, Tworoger SS, Gates MA, Cramer DW, Hankinson SE.

Carcinogenesis. 2009 Dec;30(12):2042-6. doi: 10.1093/carcin/bgp257. Epub .

18.

Common genetic variation in the IGF1 associates with maximal force output.

Huuskonen A, Lappalainen J, Oksala N, Santtila M, Häkkinen K, Kyröläinen H, Atalay M.

Med Sci Sports Exerc. 2011 Dec;43(12):2368-74. doi: 10.1249/MSS.0b013e3182220179.

PMID:
21552154
19.

IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort.

Verheus M, Maskarinec G, Woolcott CG, Haiman CA, Le Marchand L, Henderson BE, Cheng I, Kolonel LN.

Int J Cancer. 2010 Sep 1;127(5):1115-23. doi: 10.1002/ijc.25142.

20.

Associations of IGF1 and its binding proteins with abdominal aortic aneurysm and aortic diameter in older men.

Yeap BB, Chubb SA, McCaul KA, Flicker L, Ho KK, Golledge J, Hankey GJ, Norman PE.

Eur J Endocrinol. 2012 Feb;166(2):191-7. doi: 10.1530/EJE-11-0725. Epub 2011 Nov 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk